Regencell Bioscience Holdings Limited announces pricing of approximately $21.9 million initial public offering

Must Read

Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine (“TCM”) …

Latest News

Police uncover Russian-Ukrainian syndicate recruiting mercenaries

Jakarta (ANTARA) - Indonesian National Police have uncovered the operational structure of an international human trafficking network involving Russian...

More Articles Like This